0
0.5
1
1.5
2+
Mortality
4%
Improvement
Relative Risk
7-point scale
19%
Conv. Plasma PlasmAr LATE TREATMENT RCT
Is late treatment with convalescent plasma beneficial for COVID-19?
RCT 333 patients in Argentina (May - August 2020)
Improved 7-point scale results with convalescent plasma (not stat. sig., p=0.4)
c19early.org
Simonovich et al., NEJM, November 2020
Favors conv. plasma
Favors control